All of DSpace

Show simple item record

Prostate cancer: ESMO consensus conference guidelines 2012

dc.creatorHorwich, A.en
dc.creatorHugosson, J.en
dc.creatorde reijke, T.en
dc.creatorWiegel, T.en
dc.creatorFizazi, K.en
dc.creatorKataja, V.en
dc.creatorParker, C.en
dc.creatorBellmunt, J.en
dc.creatorBerthold, D.en
dc.creatorBill-axelson, A.en
dc.creatorCarlsson, S.en
dc.creatorDaugaard, G.en
dc.creatorDe meerleer, G.en
dc.creatorDe reijke, T.en
dc.creatorDearnaley, D.en
dc.creatorFonteyne, V.en
dc.creatorGillessen, S.en
dc.creatorHeinrich, D.en
dc.creatorKwiatkowski, M.en
dc.creatorNilsson, S.en
dc.creatorPadhani, A.en
dc.creatorPapandreou, C.en
dc.creatorRoobol, M.en
dc.creatorSella, A.en
dc.creatorValdagni, R.en
dc.creatorVan der kwast, T.en
dc.creatorVerhagen, P.en
dc.date.accessioned2015-11-23T10:30:09Z
dc.date.available2015-11-23T10:30:09Z
dc.date.issued2013
dc.identifier10.1093/annonc/mds624
dc.identifier.issn9237534
dc.identifier.urihttp://hdl.handle.net/11615/28504
dc.description.abstractThe first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before the conference, the expert panel prepared clinically relevant questions about prostate cancer in four areas for discussion as follows: diagnosis and staging, management of early localized disease, management of advanced localized disease and systemic disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update. © The Author 2013. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84877101072&partnerID=40&md5=a249b49ecab845631e2ba58d9e91c8ff
dc.subjectConsensusen
dc.subjectESMOen
dc.subjectProstate canceren
dc.subjectabirateroneen
dc.subjectabiraterone acetateen
dc.subjectantiandrogenen
dc.subjectbicalutamideen
dc.subjectcabazitaxelen
dc.subjectclodronic aciden
dc.subjectdenosumaben
dc.subjectdocetaxelen
dc.subjectenzalutamideen
dc.subjectgonadorelin agonisten
dc.subjectgonadorelin antagonisten
dc.subjectgonadorelin derivativeen
dc.subjectpamidronic aciden
dc.subjectplaceboen
dc.subjectprednisoneen
dc.subjectprostate specific antigenen
dc.subjectradioisotopeen
dc.subjectradium 223en
dc.subjectsipuleucel Ten
dc.subjectunclassified drugen
dc.subjectzoledronic aciden
dc.subjectageen
dc.subjectandrogen deprivation therapyen
dc.subjectarticleen
dc.subjectbone metastasisen
dc.subjectbrachytherapyen
dc.subjectcancer diagnosisen
dc.subjectcancer hormone therapyen
dc.subjectcancer localizationen
dc.subjectcancer screeningen
dc.subjectcancer stagingen
dc.subjectcastration resistant prostate canceren
dc.subjectclinical effectivenessen
dc.subjectcomorbidityen
dc.subjectdigital rectal examinationen
dc.subjectdrug efficacyen
dc.subjectdrug treatment failureen
dc.subjectEuropean Society for Medical Oncologyen
dc.subjectexternal beam radiotherapyen
dc.subjectfamily historyen
dc.subjecthumanen
dc.subjecthypocalcemiaen
dc.subjectimage guided radiotherapyen
dc.subjectintensity modulated radiation therapyen
dc.subjectjaw osteonecrosisen
dc.subjectlymph node dissectionen
dc.subjectmedical societyen
dc.subjectmetastatic hormone naive prostate canceren
dc.subjectnomogramen
dc.subjectpelvis lymph nodeen
dc.subjectpractice guidelineen
dc.subjectpriority journalen
dc.subjectprostate biopsyen
dc.subjectprostatectomyen
dc.subjectradiation doseen
dc.subjectSwitzerlanden
dc.subjectsymptomen
dc.subjecttransrectal ultrasonographyen
dc.subjectAntineoplastic Agents, Hormonalen
dc.subjectHumansen
dc.subjectLymph Nodesen
dc.subjectMaleen
dc.subjectProstate-Specific Antigenen
dc.subjectProstatic Neoplasmsen
dc.titleProstate cancer: ESMO consensus conference guidelines 2012en
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record